[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100182164":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":11,"locations":25,"responsibleParty":38,"collaborators":11,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":11,"eligibilityCriteria":45,"healthyVolunteers":46,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":11,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":60,"overallStatus":66,"whyStopped":11,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Zynex Monitoring Solutions","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Blood Draw","EXPERIMENTAL",null,[13],"Device: CM-1500",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DEVICE","CM-1500","Blood Volume Monitor",[9],[21],{"name":22,"affiliation":23,"role":24},"Nathaniel Moore, MD","Rocky Mountain Urgent Care","PRINCIPAL_INVESTIGATOR",[26],{"facility":23,"status":11,"city":27,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":11},"Aurora","Colorado","80012","United States","US",{"type":33,"coordinates":34},"Point",[35,36],-104.83192,39.72943,{"lat":36,"lon":35},{"type":39,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100182164","phase-1-clinical-evaluation-of-the-zynex-blood-volume-monitor-cm-1500-in-healthy-male-adult-subjects-during-a-blood-draw-100182164",false,"NCT01646060","Clinical Evaluation of the Zynex Blood Volume Monitor (CM-1500) in Healthy Male Adult Subjects During a Blood Draw","Inclusion Criteria:\n\n* Written informed consent\n* Male, 18-65 years of age\n* Subject is suitable for a blood draw of a pint of blood\n* Weighs at least 110 pounds\n\nExclusion Criteria:\n\n* Subject has a heart condition that may interfere with the Zynex CM-1500\n* Subject has unstable or untreated heart disease\n* Subject has been diagnosed with chronic fatigue syndrome\n* Subject is taking coumadin (warfarin), heparin, or other prescription blood thinners for at least 7 days prior to blood draw\n* Subject donated blood within 8 weeks prior to blood draw\n* Subject has high or low blood pressure on the day of blood draw\n* Subject hemoglobin \\\u003C 12.5 g\u002FdL",true,"MALE","18 Years","65 Years",{"count":51,"type":52},10,"ACTUAL","INTERVENTIONAL",[55],"PHASE1","Zynex's blood volume monitor (BVM) is a non-invasive monitoring device to monitor blood volume and blood loss of a patient during surgery, post operatively and\u002For in recovery. This monitoring device will identify baseline blood volume and relative changes in blood volume using a specific algorithm to compare and review data already monitored during surgery, displaying blood volume and blood loss in real-time.",[58,59],"Blood Loss","Healthy",[61,62,63,64,65],"blood","loss","healthy","volume","To evaluate the ability of the Zynex BVM to non-invasively detect blood loss in healthy subjects during a blood draw.","COMPLETED","2012-07-17",{"date":69,"type":70},"2012-07-20","ESTIMATED",{"date":72,"type":11},"2011-11",{"date":74,"type":52},"2011-12",{"name":5,"class":6},1]